The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

pvda: Disproportionality Functions for Pharmacovigilance

Tools for performing disproportionality analysis using the information component, proportional reporting rate and the reporting odds ratio. The anticipated use is passing data to the da() function, which executes the disproportionality analysis. See Norén et al (2011) <doi:10.1177/0962280211403604> and Montastruc et al (2011) <doi:10.1111/j.1365-2125.2011.04037.x> for further details.

Version: 0.0.3
Depends: R (≥ 2.10)
Imports: checkmate (≥ 2.1.0), cli (≥ 3.4.1), data.table (≥ 1.14.6), dplyr (≥ 1.0.10), dtplyr (≥ 1.2.2), glue (≥ 1.6.2), purrr (≥ 0.3.5), Rdpack (≥ 2.4), rlang (≥ 1.0.6), stats (≥ 4.1.3), stringr (≥ 1.5.0), tibble (≥ 3.1.8), tidyr (≥ 1.3.0), tidyselect (≥ 1.2.0), utils (≥ 4.1.3)
Suggests: knitr (≥ 1.43), rmarkdown (≥ 2.24), testthat (≥ 3.1.10), writexl (≥ 1.4.2)
Published: 2024-03-01
DOI: 10.32614/CRAN.package.pvda
Author: Oskar Gauffin ORCID iD [aut, cre]
Maintainer: Oskar Gauffin <oskar.gauffin at hotmail.com>
BugReports: https://github.com/OskarGauffin/pvda/issues
License: GPL (≥ 3)
URL: https://oskargauffin.github.io/pvda/
NeedsCompilation: no
Materials: README NEWS
CRAN checks: pvda results

Documentation:

Reference manual: pvda.pdf
Vignettes: Disproportionality analysis

Downloads:

Package source: pvda_0.0.3.tar.gz
Windows binaries: r-devel: pvda_0.0.3.zip, r-release: pvda_0.0.3.zip, r-oldrel: pvda_0.0.3.zip
macOS binaries: r-release (arm64): pvda_0.0.3.tgz, r-oldrel (arm64): pvda_0.0.3.tgz, r-release (x86_64): pvda_0.0.3.tgz, r-oldrel (x86_64): pvda_0.0.3.tgz
Old sources: pvda archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=pvda to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.